May 10–14, 2021
Hybrid Event
Shanghai and Digital

STATE OF CHINA LIFE SCIENCE: 2021

Back on track - VC, Partnering and IPOs exploding

VC/PE Fundraising

$56.1 billion; 2.3 times 2019

VC/PE Investment

$28.5 billion; 2.0 times 2019

IPOs

$23.3 billion; 2.9 times 2019

Partnering

$30.5 billion; 1.7 times 2019

In 2020, investment in China life science showed stellar growth. ChinaBio^®'s survey shows four of the five investment categories set new records, often doubling the year-earlier comparison, while the fifth, Mergers & Acquisitions, fell for the second year in a row.

Report highlights:

Complete the form to download the full report to review in greater detail the record-setting investment and partnering activity.

Get your share of the pie!

2 days in-person. 3 days virtually.

ChinaBio^®  Partnering Forum will take place on May 10–14, 2021 as our first hybrid event.
The first two days of the event will be held in-person at the ATLATL campus in Shanghai, China followed by three days of virtual one-to-one meetings, live and on-demand program sessions, company presentations and showcases, networking opportunities and much more.

In-person:

Virtual:

• One-to-one meetings
• Tabletop exhibit opportunities
• Tailored sponsorship packages

• One-to-one meetings
• Company presentation opportunities
• Company showcase opportunities
• Tailored sponsorship packages

Learn more about ChinaBio^® Partnering Forum and how you get can involved here.

READ THE REPORT

Learn more about the overall factors driving China life science investment and the key players in cross-border deals.

Terms and Conditions  |  Privacy Policy